Search results
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 5 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 4 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...
Dermatologists Reveal What Drinking Water Can Do For Your Skin
HuffPost Life via Yahoo News· 2 days agoCasey also adds that sugar and other high-glycemic index foods have been linked to acne. “Likewise,...
Principal Securities Inc. Takes $3.63 Million Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoPrincipal Securities Inc. acquired a new position in Johnson & Johnson (NYSE:JNJ – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Evergreen Wealth Management LLC
ETF DAILY NEWS· 5 days agoEvergreen Wealth Management LLC lowered its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional ...
Johnson & Johnson (NYSE:JNJ) is Valley Brook Capital Group Inc.’s 10th Largest Position
ETF DAILY NEWS· 5 days agoValley Brook Capital Group Inc. reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.7% in the 4th quarter, according to the company in its most recent Form 13F filing ...
MeadowBrook Investment Advisors LLC Takes Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoMeadowBrook Investment Advisors LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Wealthcare Advisory Partners LLC
ETF DAILY NEWS· 5 days agoWealthcare Advisory Partners LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities ...
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoIn addition, Vanda is evaluating PONVORY in additional autoimmune disorders, including psoriasis and ulcerative colitis. Prior to our acquisition, PONVORY was tested in patients ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Legacy Financial Advisors Inc.
ETF DAILY NEWS· 6 days agoLegacy Financial Advisors Inc. lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 15,541 shares of ...
